About Bhami
Bhami is a Healthcare company based in Mangaluru (India) founded in 2013 by Suryakanth Pai, Naveen Prabhu, Bhami Chennakeshava Shenoy, and Suryakanth Motilal Pai. Biotechnology research company focused on developing technologies, innovations, and high concentration protein formulations. Bhami has raised $2.41 million across 4 funding rounds from investors including Capitalbiologics, Anoop Venkat Rao and Prajnya Rao. Its chief executive, as recorded, is Suryakanth Pai. Its Indian entity Bhami's Research Laboratory Private Limited reported revenue of ₹1.26 Cr. Bhami offers products and services including HILOPRO® and Evopep. Its focus areas include Clinical Laboratories.
Company details
Bhami Research Laboratories was established in 2013 in Mangaluru, India, as a biotechnology firm. Emphasis is placed on research into high concentration protein formulations that feature reduced viscosity. Operations involve technology development for the biologics sector, including licensing agreements with entities like Catalent. Core activities center on innovations in protein-based solutions for pharmaceutical applications.
- Headquarters Mangaluru, India
- Founders Suryakanth Pai, Naveen Prabhu, Bhami Chennakeshava Shenoy, Suryakanth Motilal Pai
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website bhamilab.com
- Social LinkedIn X
- Legal Name Bhami's Research Laboratory Private Limited
- Date of Incorporation 25 May, 2013
- Jurisdiction Mangalore, Karnataka, India
- Annual Revenue₹1.26 Cr
FY 2025 · +64% YoY
- Net Loss-₹4.11 Cr
FY 2025 · -326% margin
- EBITDA-₹2.78 Cr
FY 2025 · -220% margin
- Total Equity Funding$2.41M (USD)
in 4 rounds
- Latest Funding Round$1.14M (USD), Seed
Jan 2021
Associated legal entities of Bhami
Bhami operates through Bhami's Research Laboratory Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Bhami's Research Laboratory Private Limited CIN U73100KA2013PTC069304 | Active | 25 May 2013 | Mangalore, Karnataka | ₹1.3 Cr | 3 | View details |
Products & Services of Bhami
Bhami offers a comprehensive portfolio of products and services, including HILOPRO® and Evopep.
A viscosity-reducing platform for monoclonal antibodies is provided to enable high-concentration formulations.
A platform for the oral delivery of biologics is offered, achieving proven bioavailability in in-vivo models.
Funding Insights of Bhami
Bhami has successfully raised a total of $2.41M across 4 strategic funding rounds. The most recent funding activity was a Seed round of $1.14 million completed in January 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $2.41M
- Total Rounds 4
- Last Round Seed — $1.14M
- First Round $400,863
(Mar 2015)
- Investors Count 36
All 4 funding rounds of Bhami with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2021 | $1.14M | Seed | – | Capitalbiologics | – |
| Jun 2019 | $518,879 | Seed | – | Capitalbiologics | |
| Jun 2018 | $354,454 | Angel Round | – | Chillakuru Abhirama Reddy | |
| Mar 2015 | $400,863 | Angel Round | – | Yogini Indravadan Gandhi |
36 investors in total: 1 institutional and 35 angel.
Investors in Bhami
Bhami has secured backing from 36 investors, including angel investors. Prominent investors backing the company include Capitalbiologics, Anoop Venkat Rao and Prajnya Rao.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
AV Anoop Venkat Rao | unknown_dc4fcd7cddd54c88a | |||
PR Prajnya Rao | unknown_005fa02de6864693b | |||
CA Chillakuru Abhirama Reddy | unknown_58a69ea8e4bc4defa | |||
RK Raghavendra Kudva | unknown_dfdbc399c1c64a9fb | |||
SR S Rekha Kudva | unknown_1addbe0ea51f44dcb | |||
AS Anand Shanker Prabhu | unknown_186e08ce902647f6b | |||
BM Bindu Madhav Shenoy | unknown_bf8c1c7b15a747678 | |||
MH Mangalore Harish Bhat | unknown_fa8d33c4bef64c2fa | |||
OP Om Prakash Kayyer | unknown_dbb8e4f5d19e4fb1b | |||
DS Deepak Shenoy | unknown_1b32b1a0c91f4ef7b |
Investor details for Bhami
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Bhami's Research Laboratory Private Limited (Bhami)
Bhami's Research Laboratory Private Limited is the primary company behind Bhami. The board of Bhami's Research Laboratory Private Limited currently have 3 directors; the longest-serving is Naveen Prabhu, appointed in 2013. 3 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Naveen Prabhu DIN 05237924 | Director | 25 May 2013 | 13 yrs 5 mo | Bhami's Research Laboratory Private Limited |
| Suryakanth Motilal Pai DIN 00807364 | Managing Director | 25 May 2013 | 13 yrs 5 mo | Bhami's Research Laboratory Private Limited |
| Bhami Chennakeshava Shenoy DIN 06805855 | Director | 31 Jan 2014 | 12 yrs 8 mo | Bhami's Research Laboratory Private Limited |
People of Bhami
4 people are tracked at Bhami (4 in leadership).
| Name | Role | Group |
|---|---|---|
| Co-Founder & CEO & Managing Director | Leadership | |
| Co-Founder | Leadership | |
| Co-Founder | Leadership | |
| Co-Founder & MD | Leadership |
Complete people profiles for Bhami
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Bhami
Figures of Bhami's Research Laboratory Private Limited, the primary company behind Bhami, for FY 2025. Revenue was ₹1.26 Cr (+64% year on year). Net loss was -₹4.11 Cr (-326% margin). EBITDA was -₹2.78 Cr (-220% margin). Revenue has grown at a compounded annual rate of -5% over three years and +70% over five years.
- ₹1.26 CrRevenue · FY 2025 · +64% YoY
- -₹4.11 CrNet loss · -326% margin
- -₹2.78 CrEBITDA · -220% margin
- ₹1.14 CrPaid-up capital
- -5%Revenue CAGR, 3 years
- +70%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Bhami's Research Laboratory Private Limited are on its company page.
Detailed financial statements for Bhami
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Bhami
3 dated milestones of Bhami across 8 years, from founding to its latest funding, stage changes and deals.
- Founded Bhami is founded.
- Funding First funding round of $401K.
- Funding Latest funding round, Seed, of $1.1M.
Top companies in Diagnostics Laboratories
3 companies that operate in the same segment as Bhami (Diagnostics Laboratories) in India, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Diagnostic testing centers for pathology and health screenings are operated. | 1996 | Mumbai, Maharashtra, India | USD 63.59 M | USD 88.36 M | 1,950 | |
Chain of pathology and radiology labs | 1949 | Gurugram, Haryana, India | USD 13.9 M | USD 294.49 M | 5,310 | |
Home-based diagnostic tests are booked via an online platform. | 2018 | Noida, Uttar Pradesh, India | USD 116.42 M | USD 41.86 M | 2,308 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Bhami
Bhami was founded in 2013 and raised its 1st funding round 2 years after it was founded.
Bhami is headquartered in Mangaluru, India. It is registered at Mangaluru, Karnataka, India.
Suryakanth Pai is the CEO of Bhami, as recorded in our data. They have also founded this company.
Bhami is a funded company, having raised a total of $2.41M across 4 funding rounds to date. The company's 1st funding round was a Angel Round of $400.86K, raised on Mar 2015.
The primary company behind Bhami, Bhami's Research Laboratory Private Limited, reported revenue of ₹1.26 Cr for FY 2025, up 64% year on year.
Bhami Research Laboratories was established in 2013 in Mangaluru, India, as a biotechnology firm. Emphasis is placed on research into high concentration protein formulations that feature reduced viscosity. Operations involve technology development for the biologics sector, including licensing agreements with entities like Catalent. Core activities center on innovations in protein-based solutions for pharmaceutical applications.
Bhami offers HILOPRO® and Evopep.
Bhami has 36 investors. Key investors include Capitalbiologics, Anoop Venkat Rao, Prajnya Rao, Chillakuru Abhirama Reddy, and Raghavendra Kudva.
Bhami operates through Bhami's Research Laboratory Private Limited.
The legal entities of Bhami currently have 3 directors, including Naveen Prabhu, Suryakanth Motilal Pai, Bhami Chennakeshava Shenoy.